FR08C0028I2 - - Google Patents
Info
- Publication number
- FR08C0028I2 FR08C0028I2 FR08C0028C FR08C0028C FR08C0028I2 FR 08C0028 I2 FR08C0028 I2 FR 08C0028I2 FR 08C0028 C FR08C0028 C FR 08C0028C FR 08C0028 C FR08C0028 C FR 08C0028C FR 08C0028 I2 FR08C0028 I2 FR 08C0028I2
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9420425A GB9420425D0 (en) | 1994-10-07 | 1994-10-07 | New compound |
| GBGB9508745.8A GB9508745D0 (en) | 1995-04-28 | 1995-04-28 | New compound |
| PCT/JP1995/001983 WO1996011210A1 (en) | 1994-10-07 | 1995-09-29 | Cyclic hexapeptides having antibiotic activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR08C0028I1 FR08C0028I1 (OSRAM) | 2008-08-15 |
| FR08C0028I2 true FR08C0028I2 (OSRAM) | 2009-11-20 |
Family
ID=26305774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR08C0028C Active FR08C0028I2 (OSRAM) | 1994-10-07 | 2008-06-27 |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US6107458A (OSRAM) |
| EP (1) | EP0788511B1 (OSRAM) |
| JP (2) | JP2897427B2 (OSRAM) |
| KR (1) | KR100353303B1 (OSRAM) |
| CN (1) | CN1203089C (OSRAM) |
| AR (1) | AR041770A1 (OSRAM) |
| AT (1) | ATE229541T1 (OSRAM) |
| AU (1) | AU696949B2 (OSRAM) |
| BR (2) | BRPI9504791B8 (OSRAM) |
| CA (1) | CA2202058C (OSRAM) |
| DE (2) | DE69529172T2 (OSRAM) |
| DK (1) | DK0788511T3 (OSRAM) |
| ES (1) | ES2187575T3 (OSRAM) |
| FI (1) | FI119988B (OSRAM) |
| FR (1) | FR08C0028I2 (OSRAM) |
| HU (1) | HU228151B1 (OSRAM) |
| IL (1) | IL115484A (OSRAM) |
| LU (1) | LU91452I2 (OSRAM) |
| MX (1) | MX9702531A (OSRAM) |
| NL (1) | NL300352I2 (OSRAM) |
| NO (2) | NO328483B1 (OSRAM) |
| OA (1) | OA10475A (OSRAM) |
| PT (1) | PT788511E (OSRAM) |
| RU (1) | RU2165423C2 (OSRAM) |
| TR (1) | TR199501229A2 (OSRAM) |
| WO (1) | WO1996011210A1 (OSRAM) |
Families Citing this family (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5696084A (en) * | 1996-08-16 | 1997-12-09 | Abbott Laboratories | Amino-lipopetide antifungal agents |
| AUPO371596A0 (en) * | 1996-11-19 | 1996-12-12 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
| AUPO381496A0 (en) * | 1996-11-25 | 1996-12-19 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
| EP0994101A4 (en) * | 1997-06-18 | 2002-05-02 | Fujisawa Pharmaceutical Co | NEW PREPARATION PROCESS |
| AU756792B2 (en) * | 1998-02-09 | 2003-01-23 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
| TR200003064T2 (tr) * | 1998-02-09 | 2001-02-21 | Fujisawa Pharmaceutical Co; Ltd. | Yeni bileşik |
| US7084279B1 (en) * | 1999-02-11 | 2006-08-01 | Emisphere Technologies Inc. | Oxadiazole compounds and compositions for delivering active agents |
| DE60024414T2 (de) * | 1999-02-11 | 2006-06-14 | Emisphere Tech Inc | Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen |
| AUPP999799A0 (en) * | 1999-04-27 | 1999-05-20 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
| AUPQ066399A0 (en) * | 1999-05-31 | 1999-06-24 | Fujisawa Pharmaceutical Co., Ltd. | Antifungal combination use |
| TWI233805B (en) | 1999-07-01 | 2005-06-11 | Fujisawa Pharmaceutical Co | Stabilized pharmaceutical composition in lyophilized form as antifungal agent |
| US7166572B1 (en) | 1999-07-27 | 2007-01-23 | Aventis Pharma Deutschland Gmbh | Cyclohexapeptide compounds, processes for their production and their use as a pharmaceutical |
| AUPQ462399A0 (en) * | 1999-12-13 | 2000-01-13 | Fujisawa Pharmaceutical Co., Ltd. | New use |
| TWI250992B (en) | 2000-02-21 | 2006-03-11 | Astellas Pharma Inc | Polypeptide compounds for the prophylactic and/or therapeutic treatment of infectious diseases caused by pathogenic microorganisms |
| ES2191516B1 (es) * | 2000-07-28 | 2005-01-01 | Consejo Superior De Investigaciones Cientificas | Antibioticos antifungicos de naturaleza peptidica inhibidores de la germinacion y el crecimiento de hongos fitopatogenos. |
| AUPQ938700A0 (en) * | 2000-08-14 | 2000-09-07 | Fujisawa Pharmaceutical Co., Ltd. | Antifungal combination use |
| EP1356816B1 (en) | 2001-01-29 | 2009-12-23 | Shionogi & Co., Ltd. | Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient |
| JP2005053782A (ja) * | 2001-08-31 | 2005-03-03 | Fujisawa Pharmaceut Co Ltd | 環状リポペプチド化合物の新規結晶 |
| CA2477088A1 (en) | 2002-02-22 | 2003-10-02 | New River Pharmaceuticals Inc. | Active agent delivery systems and methods for protecting and administering active agents |
| WO2004014879A1 (en) * | 2002-08-08 | 2004-02-19 | Fujisawa Pharmaceutical Co., Ltd. | New process |
| AU2003903205A0 (en) * | 2003-06-23 | 2003-07-10 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
| EP1654036B1 (en) * | 2003-07-22 | 2007-12-26 | Theravance, Inc. | Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent |
| EP1663275A2 (en) * | 2003-09-05 | 2006-06-07 | Merck & Co., Inc. | Stationary phases and a purification process using the stationary phases |
| ATE547404T1 (de) * | 2003-09-22 | 2012-03-15 | Msd Kk | Piperidinderivate |
| US7476673B2 (en) * | 2003-12-30 | 2009-01-13 | Allergan, Inc. | Disubstituted chalcone oximes as selective agonists of RARγ retinoid receptors |
| US20050261365A1 (en) * | 2004-05-20 | 2005-11-24 | The Scripps Research Institute | Transthyretin stabilization |
| CA2580844A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase |
| US7919496B2 (en) | 2004-09-20 | 2011-04-05 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes |
| WO2006034441A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| CN101084211A (zh) | 2004-09-20 | 2007-12-05 | 泽农医药公司 | 杂环衍生物及其作为治疗剂的用途 |
| JP4958785B2 (ja) | 2004-09-20 | 2012-06-20 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | 複素環誘導体およびステアロイル−ＣｏＡデサチュラーゼインヒビターとしてのそれらの使用 |
| US7767677B2 (en) | 2004-09-20 | 2010-08-03 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
| AR051094A1 (es) | 2004-09-20 | 2006-12-20 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa |
| JP2008515992A (ja) * | 2004-10-13 | 2008-05-15 | ピーティーシー セラピューティクス，インコーポレーテッド | 体細胞変異に起因する疾患の阻止／治療用医薬を製造するための規定化合物の使用 |
| EP2540296A1 (en) | 2005-06-03 | 2013-01-02 | Xenon Pharmaceuticals Inc. | Arminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
| US7947707B2 (en) * | 2005-10-07 | 2011-05-24 | Kissei Pharmaceutical Co., Ltd. | Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| CN101516387B (zh) * | 2006-07-26 | 2014-06-04 | 桑多斯股份公司 | 卡泊芬净制剂 |
| US8853392B2 (en) | 2007-06-03 | 2014-10-07 | Vanderbilt University | Benzamide mGluR5 positive allosteric modulators and methods of making and using same |
| CN104054719B (zh) | 2007-08-13 | 2016-09-28 | 孟山都技术有限责任公司 | 用于控制线虫的组合物和方法 |
| TW200934507A (en) * | 2007-10-29 | 2009-08-16 | Astellas Pharma Inc | Polypeptide compounds |
| US8034806B2 (en) | 2007-11-02 | 2011-10-11 | Vanderbilt University | Bicyclic mGluR5 positive allosteric modulators and methods of making and using same |
| KR101273765B1 (ko) * | 2008-06-24 | 2013-06-12 | 아이알엠 엘엘씨 | Ｇ 단백질-커플링된 수용체를 조정하는 화합물 및 방법 |
| US9394340B2 (en) | 2009-03-24 | 2016-07-19 | Cadila Healthcare Limited | Purification process for lipopeptides |
| BR112013023531A2 (pt) * | 2011-04-04 | 2016-12-06 | Xellia Pharmaceuticals Aps | processo de um único vaso para a fabricação de micafungina ou de um sal desta |
| HUE027806T2 (en) | 2011-04-20 | 2016-11-28 | Xellia Pharmaceuticals Aps | A method for purifying micafungin |
| CN102775476B (zh) * | 2011-05-12 | 2015-01-07 | 上海天伟生物制药有限公司 | 一种米卡芬净钠盐的制备方法 |
| WO2012158844A1 (en) | 2011-05-17 | 2012-11-22 | Shionogi & Co., Ltd. | Heterocyclic compounds |
| RU2014113624A (ru) * | 2011-09-09 | 2015-10-20 | Сандоз Аг | Получение промежуточных продуктов для получения микафунгина |
| CN102659930B (zh) | 2012-03-30 | 2014-04-23 | 上海天伟生物制药有限公司 | 一种高纯度环肽类物质的晶体及其制备方法和用途 |
| CN102627689B (zh) * | 2012-03-30 | 2014-08-06 | 上海天伟生物制药有限公司 | 一种环肽类化合物的水合物及其制备方法和用途 |
| CN102627688B (zh) | 2012-03-30 | 2014-12-31 | 上海天伟生物制药有限公司 | 一种高纯度环肽化合物及其制备方法和用途 |
| EP3150621A4 (en) * | 2014-05-29 | 2017-12-27 | Shanghai Techwell Biopharmaceutical Co., Ltd | Composition of cyclic peptide compound, preparation method for same, and uses thereof |
| CN104861044B (zh) * | 2014-05-29 | 2019-03-01 | 上海天伟生物制药有限公司 | 一种环肽类化合物的溶剂合物及其制备方法和用途 |
| WO2016056023A2 (en) * | 2014-10-07 | 2016-04-14 | Alaparthi Lakshmi Prasad | Intermediates and processes to prepare micafungin |
| CA2937365C (en) | 2016-03-29 | 2018-09-18 | F. Hoffmann-La Roche Ag | Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same |
| US12403173B2 (en) | 2016-12-16 | 2025-09-02 | Baxter International Inc. | Micafungin compositions |
| EP3485873A1 (en) | 2017-11-17 | 2019-05-22 | Cadila Healthcare Limited | Stable pharmaceutical injectable compositions of micafungin |
| CN108752430B (zh) * | 2018-05-31 | 2022-02-18 | 杭州中美华东制药有限公司 | 米卡芬净钠新晶型及其制备方法 |
| WO2020013116A1 (ja) * | 2018-07-10 | 2020-01-16 | 京都薬品工業株式会社 | Ｐｔｐ－１ｂ阻害剤およびその用途 |
| CN110734408A (zh) * | 2019-10-22 | 2020-01-31 | 重庆康乐制药有限公司 | 一种米卡芬净类衍生物侧链中间体的制备方法 |
| CN115785226A (zh) * | 2021-09-09 | 2023-03-14 | 上海天伟生物制药有限公司 | 一种棘白菌素药物杂质及其制备、纯化方法和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1574603A1 (ru) * | 1988-08-11 | 1990-06-30 | Ивановский Химико-Технологический Институт | Способ получени мезо-тетраарилоктаметилпорфиринов |
| IE990233A1 (en) * | 1990-06-18 | 2000-11-15 | Fujisawa Pharmaceutical Co | New Polypeptide Compound and a Process for Preparation thereof |
| CZ288974B6 (cs) * | 1992-03-19 | 2001-10-17 | Eli Lilly And Company | Acylový derivát echinocandinu, způsob jeho přípravy, farmaceutický prostředek s jeho obsahem a jeho pouľití |
-
1995
- 1995-09-29 DE DE69529172T patent/DE69529172T2/de not_active Expired - Lifetime
- 1995-09-29 RU RU97107338/04A patent/RU2165423C2/ru active Protection Beyond IP Right Term
- 1995-09-29 DK DK95932935T patent/DK0788511T3/da active
- 1995-09-29 DE DE122008000025C patent/DE122008000025I2/de active Active
- 1995-09-29 EP EP95932935A patent/EP0788511B1/en not_active Expired - Lifetime
- 1995-09-29 MX MX9702531A patent/MX9702531A/es unknown
- 1995-09-29 JP JP8512472A patent/JP2897427B2/ja not_active Expired - Lifetime
- 1995-09-29 CA CA002202058A patent/CA2202058C/en not_active Expired - Lifetime
- 1995-09-29 CN CNB95196643XA patent/CN1203089C/zh not_active Expired - Lifetime
- 1995-09-29 WO PCT/JP1995/001983 patent/WO1996011210A1/en not_active Ceased
- 1995-09-29 PT PT95932935T patent/PT788511E/pt unknown
- 1995-09-29 US US08/809,723 patent/US6107458A/en not_active Expired - Lifetime
- 1995-09-29 KR KR1019970702213A patent/KR100353303B1/ko not_active Expired - Lifetime
- 1995-09-29 AT AT95932935T patent/ATE229541T1/de active
- 1995-09-29 AU AU35780/95A patent/AU696949B2/en not_active Expired
- 1995-09-29 ES ES95932935T patent/ES2187575T3/es not_active Expired - Lifetime
- 1995-09-29 HU HU9800338A patent/HU228151B1/hu active Protection Beyond IP Right Term
- 1995-10-02 IL IL11548495A patent/IL115484A/xx not_active IP Right Cessation
- 1995-10-06 BR BRPI9504791A patent/BRPI9504791B8/pt not_active IP Right Cessation
- 1995-10-06 TR TR95/01229A patent/TR199501229A2/xx unknown
- 1995-10-06 AR ARP9501333763A patent/AR041770A1/es unknown
- 1995-10-06 BR BRPI9504791-3A patent/BR9504791B1/pt active IP Right Grant
-
1997
- 1997-04-04 NO NO19971544A patent/NO328483B1/no not_active IP Right Cessation
- 1997-04-04 FI FI971397A patent/FI119988B/fi not_active IP Right Cessation
- 1997-04-17 OA OA60989A patent/OA10475A/en unknown
-
1998
- 1998-05-19 JP JP13675698A patent/JP3518665B2/ja not_active Expired - Lifetime
-
1999
- 1999-02-11 US US09/248,267 patent/US6265536B1/en not_active Expired - Lifetime
-
2008
- 2008-06-03 NL NL300352C patent/NL300352I2/nl unknown
- 2008-06-04 LU LU91452C patent/LU91452I2/fr unknown
- 2008-06-27 FR FR08C0028C patent/FR08C0028I2/fr active Active
-
2010
- 2010-08-09 NO NO2010016C patent/NO2010016I2/no unknown